Fosun Pharma (02196) Proposes Executive Director Election, Schedules EGM in December

Bulletin Express

2025/11/07

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has released details of an upcoming extraordinary general meeting (EGM) to vote on the proposed election of a new executive director. The EGM is set for December 2, 2025, at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.

The candidate for executive director is Liu Yi, currently serving as the chief executive officer and president of the company. If approved, Liu Yi’s term will extend until the end of the tenth session of the board. According to the announcement, Liu Yi holds personal interests in 15,444 A shares and 20,000 H shares of the company.

The register of H shareholders is scheduled to close from November 27 to December 2, 2025 (inclusive), with the record date on December 2, 2025. Unregistered H shareholders intending to vote at the meeting should submit relevant transfer documents by 4:30 p.m. on November 26, 2025.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1120611204"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120611204\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120611204?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 16:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120611204","market":"us","top_or_hot":-1,"title":"Fosun Pharma (02196) Proposes Executive Director Election, Schedules EGM in December","media":"Bulletin Express","content":"<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has released details of an upcoming extraordinary general meeting (EGM) to vote on the proposed election of a new executive director. The EGM is set for December 2, 2025, at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.</p>\n<p>The candidate for executive director is Liu Yi, currently serving as the chief executive officer and president of the company. If approved, Liu Yi’s term will extend until the end of the tenth session of the board. According to the announcement, Liu Yi holds personal interests in 15,444 A shares and 20,000 H shares of the company.</p>\n<p>The register of H shareholders is scheduled to close from November 27 to December 2, 2025 (inclusive), with the record date on December 2, 2025. Unregistered H shareholders intending to vote at the meeting should submit relevant transfer documents by 4:30 p.m. on November 26, 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fosun Pharma (02196) Proposes Executive Director Election, Schedules EGM in December</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFosun Pharma (02196) Proposes Executive Director Election, Schedules EGM in December\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2025-11-07 16:22</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has released details of an upcoming extraordinary general meeting (EGM) to vote on the proposed election of a new executive director. The EGM is set for December 2, 2025, at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.</p>\n<p>The candidate for executive director is Liu Yi, currently serving as the chief executive officer and president of the company. If approved, Liu Yi’s term will extend until the end of the tenth session of the board. According to the announcement, Liu Yi holds personal interests in 15,444 A shares and 20,000 H shares of the company.</p>\n<p>The register of H shareholders is scheduled to close from November 27 to December 2, 2025 (inclusive), with the record date on December 2, 2025. Unregistered H shareholders intending to vote at the meeting should submit relevant transfer documents by 4:30 p.m. on November 26, 2025.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"復星醫藥","start_time":0,"source_url":"","article_id":"1120611204","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120611204","pubTimestamp":1762503746,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has released details of an upcoming extraordinary general meeting (EGM) to vote on the proposed election of a new executive director. The EGM...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02196":"复星医药"},"translate_title":"复星医药(02196)建议选举执行董事安排12月临时股东大会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02196":1},"content_text":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has released details of an upcoming extraordinary general meeting (EGM) to vote on the proposed election of a new executive director. The EGM is set for December 2, 2025, at 1:30 p.m., to be held at Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.\nThe candidate for executive director is Liu Yi, currently serving as the chief executive officer and president of the company. If approved, Liu Yi’s term will extend until the end of the tenth session of the board. According to the announcement, Liu Yi holds personal interests in 15,444 A shares and 20,000 H shares of the company.\nThe register of H shareholders is scheduled to close from November 27 to December 2, 2025 (inclusive), with the record date on December 2, 2025. Unregistered H shareholders intending to vote at the meeting should submit relevant transfer documents by 4:30 p.m. on November 26, 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}